Autopsy Case Report and Review of the Literature Karyna C
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Membrane Attack Complex in Myocardial Ischemia/Reperfusion Injury: a Systematic Review for Post Mortem Applications
diagnostics Review Membrane Attack Complex in Myocardial Ischemia/Reperfusion Injury: A Systematic Review for Post Mortem Applications Cristina Mondello 1,*, Elvira Ventura Spagnolo 2,*, Luigi Cardia 3 , Daniela Sapienza 1, Serena Scurria 1, Patrizia Gualniera 1 and Alessio Asmundo 1 1 Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, via Consolare Valeria, 1, 98125 Messina, Italy; [email protected] (D.S.); [email protected] (S.S.); [email protected] (P.G.); [email protected] (A.A.) 2 Section Legal Medicine, Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Via del Vespro, 129, 90127 Palermo, Italy 3 IRCCS Centro Neurolesi Bonino-Pulejo, 98100 Messina, Italy; [email protected] * Correspondence: [email protected] (C.M.); [email protected] (E.V.S.); Tel.: +39-347062414 (C.M.); +39-3496465532 (E.V.S.) Received: 19 October 2020; Accepted: 31 October 2020; Published: 2 November 2020 Abstract: The complement system has a significant role in myocardial ischemia/reperfusion injury, being responsible for cell lysis and amplification of inflammatory response. In this context, several studies highlight that terminal complement complex C5b-9, also known as the membrane attack complex (MAC), is a significant contributor. The MAC functions were studied by many researchers analyzing the characteristics of its activation in myocardial infarction. Here, a systematic literature review was reported to evaluate the principal features, advantages, and limits (regarding the application) of complement components and MAC in post mortem settings to perform the diagnosis of myocardial ischemia/infarction. The review was performed according to specific inclusion and exclusion criteria, and a total of 26 studies were identified. -
Absolute Measurement of the Tissue Origins of Cell-Free DNA in the Healthy State and Following Paracetamol Overdose Danny Laurent1, Fiona Semple1, Philip J
Laurent et al. BMC Medical Genomics (2020) 13:60 https://doi.org/10.1186/s12920-020-0705-2 RESEARCH ARTICLE Open Access Absolute measurement of the tissue origins of cell-free DNA in the healthy state and following paracetamol overdose Danny Laurent1, Fiona Semple1, Philip J. Starkey Lewis2, Elaine Rose1, Holly A. Black1, Jennifer Coe1, Stuart J. Forbes2, Mark J. Arends3, James W. Dear4 and Timothy J. Aitman1* Abstract Background: Despite the emergence of cell-free DNA (cfDNA) as a clinical biomarker in cancer, the tissue origins of cfDNA in healthy individuals have to date been inferred only by indirect and relative measurement methods, such as tissue-specific methylation and nucleosomal profiling. Methods: We performed the first direct, absolute measurement of the tissue origins of cfDNA, using tissue-specific knockout mouse strains, in both healthy mice and following paracetamol (APAP) overdose. We then investigated the utility of total cfDNA and the percentage of liver-specific cfDNA as clinical biomarkers in patients presenting with APAP overdose. Results: Analysis of cfDNA from healthy tissue-specific knockout mice showed that cfDNA originates predominantly from white and red blood cell lineages, with minor contribution from hepatocytes, and no detectable contribution from skeletal and cardiac muscle. Following APAP overdose in mice, total plasma cfDNA and the percentage fraction originating from hepatocytes increased by ~ 100 and ~ 19-fold respectively. Total cfDNA increased by an average of more than 236-fold in clinical samples from APAP overdose patients with biochemical evidence of liver injury, and 18-fold in patients without biochemically apparent liver injury. Measurement of liver-specific cfDNA, using droplet digital PCR and methylation analysis, revealed that the contribution of liver to cfDNA was increased by an average of 175-fold in APAP overdose patients with biochemically apparent liver injury compared to healthy subjects, but was not increased in overdose patients with normal liver function tests. -
Antenatal Corticosteroid Use and Clinical Evolution of Preterm Newborn Infants
0021-7557/04/80-04/277 Jornal de Pediatria Copyright © 2004 by Sociedade Brasileira de Pediatria ARTIGO ORIGINAL Uso antenatal de corticosteróide e evolução clínica de recém-nascidos pré-termo Antenatal corticosteroid use and clinical evolution of preterm newborn infants Rede Brasileira de Pesquisas Neonatais* Resumo Abstract Objetivo: Descrever a freqüência de utilização de corticosteróide Objectives: To describe the use of antenatal corticosteroid and antenatal e a evolução clínica dos recém-nascidos pré-termo. clinical evolution of preterm babies. Métodos: Estudo observacional prospectivo tipo coorte de todos Methods: An observational prospective cohort study was carried os neonatos com idade gestacional entre 23 e 34 semanas nascidos na out. All 463 pregnant women and their 514 newborn babies with Rede Brasileira de Pesquisas Neonatais entre agosto e dezembro de gestational age ranging from 23 to 34 weeks, born at the Brazilian 2001. Os prontuários médicos foram revistos, as mães entrevistadas e Neonatal Research Network units, were evaluated from August 1 to os pré-termos acompanhados. A análise dos dados foi realizada com o December 31, 2001. The data were obtained through maternal interview, teste do qui-quadrado, t de Student, Mann-Whitney, ANOVA e regres- analysis of medical records, and follow-up of the newborn infants. Data são logística múltipla, com nível de significância de 5%. analysis was performed with the use of chi-square, t Student, Mann- Resultados: Avaliaram-se 463 gestantes e seus 514 recém- Whitney, and ANOVA tests and multiple logistic regression, with level nascidos. As gestantes tratadas tiveram mais gestações prévias, of significance set at 5%. consultas de pré-natal, hipertensão arterial e maior uso de tocolíticos. -
Burn Wound Infec Tion Infection Is One of the Commonest Causes of Death in Burn Patients, Particularly Those with Extensive Damage
Burn wound infec tion Infection is one of the commonest causes of death in burn patients, particularly those with extensive damage. H RODE, MB ChB, MMed (Surg), FCS (SA), FRCS (Ed) Professor Rode is Emeritus Professor of Paediatric Surgery at the Red Cross War Memorial Children’s Hospital and the University of Cape Town. He became Chief Specialist and Head of the Department in 1997. He is the past president of the South African Association of Paediatric Surgeons (SAAPS), the South African Burn Association and the Child Accident Prevention Foundation of Southern Africa. He was secretary to SAAPS, the Finance and General Purpose Committee of the Colleges of Medicine, the European Club for Paediatric Burns and the Pan-African Paediatric Surgical Association and is on the Executive Committee of the College of Surgeons. He serves on the editorial board of 3 paediatric surgical journals, has a lifetime interest in thermal injuries and has written extensively on the subject. I DO VALE, MB ChB Dr I do Vale graduated MB ChB from the University of the Witwatersrand in 2006 and is currently working as a medical officer in the Department of Surgery in the Johannesburg General Hospital. She has successfully completed the ACLS, BSS and ATLS courses as well as the primary examination from the CMSA. She wants to specialise in plastic and reconstructive surgery, focusing on congenital hand surgery, reconstruction of burn injuries and cleft palate repair. A J W MILLAR, MB ChB, FRCS (Ed), FRCS (Eng), DCH, FRACS, FCS (SA) Professor Millar qualified at the University of Cape Town with surgical training in paediatric and general surgery in the UK, the Red Cross War Memorial Children’s Hospital, and the Royal Children’s Hospital, Melbourne. -
Insulin Enhancement of the Antitumor Activity of Chemotherapeutic Agents
www.nature.com/scientificreports OPEN Insulin enhancement of the antitumor activity of chemotherapeutic agents in colorectal cancer is linked with downregulating PIK3CA and GRB2 Siddarth Agrawal1*, Marta Woźniak1, Mateusz Łuc1, Sebastian Makuch1, Ewa Pielka1, Anil Kumar Agrawal2, Joanna Wietrzyk 3, Joanna Banach3, Andrzej Gamian4, Monika Pizon5 & Piotr Ziółkowski1 The present state of cancer chemotherapy is unsatisfactory. New anticancer drugs that marginally improve the survival of patients continue to be developed at an unsustainably high cost. The study aimed to elucidate the efects of insulin (INS), an inexpensive drug with a convincing safety profle, on the susceptibility of colon cancer to chemotherapeutic agents: 5-fuorouracil (FU), oxaliplatin (OXA), irinotecan (IRI), cyclophosphamide (CPA) and docetaxel (DOC). To examine the efects of insulin on cell viability and apoptosis, we performed an in vitro analysis on colon cancer cell lines Caco-2 and SW480. To verify the results, we performed in vivo analysis on mice bearing MC38 colon tumors. To assess the underlying mechanism of the therapy, we examined the mRNA expression of pathways related to the signaling downstream of insulin receptors (INSR). Moreover, we performed Western blotting to confrm expression patterns derived from the genetic analysis. For the quantifcation of circulating tumor cells in the peripheral blood, we used the maintrac method. The results of our study show that insulin- pretreated colon cancer cells are signifcantly more susceptible to commonly used chemotherapeutics. The apoptosis ratio was also enhanced when INS was administered complementary to the examined drugs. The in vivo study showed that the combination of INS and FU resulted in signifcant inhibition of tumor growth and reduction of the number of circulating tumor cells. -
Chronic Lymphocytic Leukemia in a Black
L OPEN ACCESS Freely available online al of euk rn em u i o a J Journal of Leukemia ISSN: 2329-6917 Case Report Chronic Lymphocytic Leukemia in A Black African Man: A Cameroonian Case Report Raspail Carrel Founou1*, Julius Nwobegahay2, Regine Gandji3, Cedrice Tsayem4, Sandra Yopa5, Martin Kuete6 and Luria Leslie Founou7 1Department of Clinical Microbiology, Centre of Expertise and Biological Diagnostic of Cameroon (CEDBCAM), Yaounde, Cameroon; 2Military Health Research Centre (CRESAR), Yaounde, Cameroon; 3Department of Biological Sciences, Higher Institute of Medical Technology, Yaoundé, Cameroon; 4Department of Clinical Biochemistry, Centre of Expertise and Biological Diagnostic of Cameroon (CEDBCAM), Yaounde, Cameroon; 5Department of Emergency, District Hospital of Biyem-Assi, Yaounde, Cameroon; 6Department of Biomedical and Applied Health, Faculty of Health Sciences, Université des Montagnes, Bangante, Cameroon; 7Department of Food Safety and Environmental Microbiology, Centre of Expertise and Biological Diagnostic of Cameroon (CEDBCAM), Yaounde, Cameroo ABSTRACT Chronic Lymphocytic Leukemia (CLL) is an acquired monoclonal disorder characterized by a gradual accumulation of functionally incompetent lymphocytes. It generally presents a clonal B cells arrested in the B-cell differentiation pathway that resemble morphologically to mature lymphocytes in the peripheral blood. There is a scarcity of CLL data among sub-Saharan African countries such as Cameroon. We herein report a case of CLL that remained stable over a period of seven years in a 54 years old Black African man. The patient had no history of exposure to toxic chemicals or ionizing radiation and presented with several complaints and clinical symptoms. Clinical and laboratory investigations indicated a CLL in stage B of the Binet staging system. -
Early-Onset Neonatal Sepsis: a Continuing Problem in Need of Novel Prevention Strategies Barbara J
Early-Onset Neonatal Sepsis: A Continuing Problem in Need of Novel Prevention Strategies Barbara J. Stoll, MD Early-onset neonatal sepsis (EOS) colonized women or targeted IAP for remains a feared cause of severe women with obstetrical risk factors illness and death among infants of all in labor known to increase GBS birthweights and gestational ages, transmission. 5 Revised guidelines with particular impact among preterm in 2002 recommended universal infants. Centers for Disease Control and antenatal screening for GBS at 35 to Prevention investigators have studied 37 weeks’ gestational age to identify the changing epidemiology of invasive colonized women who should receive EOS for several decades. The Active IAP. 6 Guidelines were additionally Bacterial Core surveillance (ABCs) refined in 2010 to provide neonatal network, a collaboration between management recommendations based the Centers for Disease Control and on maternal risk factors and clinical H. Wayne Hightower Distinguished Professor in the Medical Prevention, state health departments, condition of the infant at birth, with Sciences and Dean, McGovern Medical School, University of and universities, was established in an attempt to reduce unnecessary Texas Health Science Center at Houston, Houston, Texas 1995 to address emerging infectious evaluations of well-appearing infants Opinions expressed in these commentaries are diseases of public health importance, without risk factors. 7 Widespread those of the author and not necessarily those of the including infections due to major adherence to national guidelines American Academy of Pediatrics or its Committees. neonatal pathogens. 1, 2 ABCs data resulted in a remarkable decline DOI: 10.1542/peds.2016-3038 are remarkable because of the in early onset GBS disease, but a Accepted for publication Sep 12, 2016 geographic distribution and size of the concomitant increase in exposure Address correspondence to Barbara J. -
Pathological Study of Facial Eczema (Pithomycotoxicosis) in Sheep
animals Article Pathological Study of Facial Eczema (Pithomycotoxicosis) in Sheep Miguel Fernández 1,2,* , Valentín Pérez 1,2 , Miguel Fuertes 3, Julio Benavides 2, José Espinosa 1,2 , Juan Menéndez 4,†, Ana L. García-Pérez 3 and M. Carmen Ferreras 1,2 1 Departamento de Sanidad Animal, Facultad de Veterinaria, Universidad de León, C/Prof. Pedro Cármenes s/n, E-24071 León, Spain; [email protected] (V.P.); [email protected] (J.E.); [email protected] (M.C.F.) 2 Instituto de Ganadería de Montaña (IGM), CSIC-Universidad de León, Finca Marzanas s/n, E-24346 León, Spain; [email protected] 3 Department of Animal Health, NEIKER-Basque Institute for Agricultural Research and Development, Basque Research and Technology Alliance (BRTA), Parque Científico y Tecnológico de Bizkaia, P812, E-48160 Derio, Spain; [email protected] (M.F.); [email protected] (A.L.G.-P.) 4 Area de Sistemas de Producción Animal, Servicio Regional de Investigación y Desarrollo Agroalimentario, SERIDA, E-33300 Villaviciosa, Asturias, Spain; [email protected] * Correspondence: [email protected]; Tel.: +34-987-291232 † Current address: Centro Veterinario Albéitar, E-33204 Gijón, Spain. Simple Summary: Facial eczema (FE) is a secondary photosensitization disease of farm ruminants caused by the sporidesmin A, present in the spores of the saprophytic fungus Pithomyces chartarum. This study communicates an outbreak of ovine FE in Asturias (Spain) and characterizes the local immune response that may contribute to liver damage promoting cholestasis and progression Citation: Fernández, M.; Pérez, V.; towards fibrosis and cirrhosis. Animals showed clinical signs of photosensitivity and lower gain Fuertes, M.; Benavides, J.; Espinosa, J.; Menéndez, J.; García-Pérez, A.L.; of weight, loss of wool and crusting in the head for at least 6 months after the FE outbreak. -
Generating Real-World Evidence by Strengthening Real-World Data Sources
Generating Real-World Evidence by Strengthening Real-World Data Sources Using “real-world evidence” to bring new “Every day, health care professionals are updating patients’ treatments to patients as part of the 21st electronic health records with data on clinical outcomes Century Cures Act (the “Cures Act”) is a key resulting from medical interventions used in routine clinical priority for the Department of Health and practice. As our experience with new medical products Human Services (HHS). Specifically, the Cures expands, our knowledge about how to best maximize their Act places focus on the use of real-world data benefits and minimize potential risks sharpens with each data to support regulatory decision-making, including point we gather. Every clinical use of a product produces data the approval of new indications for existing that can help better inform us about its safety and efficacy.” drugs in order to make drug development faster jacqueline corrigan-curay, md, jd and more efficient. As such, the Cures Act director of the office of medical policy in fda’s center for drug evaluation and research has tasked the Food and Drug Administration (FDA) to develop a framework and guidance for evaluating real-world evidence in the context of drug regulation.1 Under the FDA’s framework, real-world evidence (RWE) is generated by different study designs or analyses, including but not limited to, randomized trials like large simple trials, pragmatic trials, and observational studies. RWE is the clinical evidence about the use, potential benefits, and potential risks of a medical product based on an analysis of real-world data (RWD). -
The Value of Case Reports in Systematic Reviews from Rare Diseases
International Journal of Environmental Research and Public Health Article The Value of Case Reports in Systematic Reviews from Rare Diseases. The Example of Enzyme Replacement Therapy (ERT) in Patients with Mucopolysaccharidosis Type II (MPS-II) Miguel Sampayo-Cordero 1,2,*, Bernat Miguel-Huguet 3, Andrea Malfettone 1,2, José Manuel Pérez-García 1,2,4, Antonio Llombart-Cussac 1,2,5, Javier Cortés 1,2,4,6, Almudena Pardo 7 and Jordi Pérez-López 8 1 Medica Scientia Innovation Research (MedSIR), Ridgewood, NJ 07450, USA; [email protected] (A.M.); [email protected] (J.M.P.-G.); [email protected] (A.L.-C.); [email protected] (J.C.) 2 Medica Scientia Innovation Research (MedSIR), 08018 Barcelona, Spain 3 Department of Surgery, Hospital de Bellvitge, L’Hospitalet de Llobregat, 08907 Barcelona, Spain; [email protected] 4 Institute of Breast Cancer, Quiron Group, 08023 Barcelona, Spain 5 Hospital Arnau de Vilanova, Universidad Católica de Valencia “San Vicente Mártir”, 46015 Valencia, Spain 6 Vall d’Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain 7 Albiotech Consultores y Redacción Científica S.L., 28035 Madrid, Spain; [email protected] 8 Department of Internal Medicine, Hospital Vall d’Hebron, 08035 Barcelona, Spain; [email protected] * Correspondence: [email protected] Received: 3 August 2020; Accepted: 7 September 2020; Published: 10 September 2020 Abstract: Background: Case reports are usually excluded from systematic reviews. Patients with rare diseases are more dependent on novel individualized strategies than patients with common diseases. We reviewed and summarized the novelties reported by case reports in mucopolysaccharidosis type II (MPS-II) patients treated with enzyme replacement therapy (ERT). -
Repeatability Case Study of the 3D Printer in the School of Engineering and Applied Science Lab Naif Faleh S
Western Kentucky University TopSCHOLAR® Masters Theses & Specialist Projects Graduate School Spring 2018 Repeatability Case Study of the 3D Printer in the School of Engineering and Applied Science Lab Naif Faleh S. Albaiji Western Kentucky University, [email protected] Follow this and additional works at: https://digitalcommons.wku.edu/theses Part of the Ergonomics Commons, Industrial Engineering Commons, Operational Research Commons, and the Other Operations Research, Systems Engineering and Industrial Engineering Commons Recommended Citation Albaiji, Naif Faleh S., "Repeatability Case Study of the 3D Printer in the School of Engineering and Applied Science Lab" (2018). Masters Theses & Specialist Projects. Paper 2359. https://digitalcommons.wku.edu/theses/2359 This Thesis is brought to you for free and open access by TopSCHOLAR®. It has been accepted for inclusion in Masters Theses & Specialist Projects by an authorized administrator of TopSCHOLAR®. For more information, please contact [email protected]. REPEATABILITY CASE STUDY OF THE 3D PRINTER IN THE SCHOOL OF ENGINEERING AND APPLIED SCIENCES LAB A Thesis Presented to The Faculty of the School of Engineering and Applied Science Western Kentucky University Bowling Green, Kentucky In Partial Fulfillment Of the Requirements for the Degree Master of Science By Naif Albaiji May 2018 I dedicate this thesis to my family, especially my mother, Laila Altaie, my father, Faleh, and my brother, Fawaz Albaiji. They have supported me since day one to ensure that I find my way to success. I also dedicate this work to the School of Engineering and Applied Science, my thesis committee, and my professors who have guided me. ACKNOWLEDGMENTS I would like to thank several people who inspired and helped me throughout my journey with this study and degree: Dr. -
EPI Case Study 1 Incidence, Prevalence, and Disease
EPIDEMIOLOGY CASE STUDY 1: Incidence, Prevalence, and Disease Surveillance; Historical Trends in the Epidemiology of M. tuberculosis STUDENT VERSION 1.0 EPI Case Study 1: Incidence, Prevalence, and Disease Surveillance; Historical Trends in the Epidemiology of M. tuberculosis Estimated Time to Complete Exercise: 30 minutes LEARNING OBJECTIVES At the completion of this Case Study, participants should be able to: ¾ Explain why denominators are necessary when comparing changes in morbidity and mortality over time ¾ Distinguish between incidence rates and prevalence ratios ¾ Calculate and interpret cause-specific morbidity and mortality rates ¾ Describe how changes in mortality or morbidity could be due to an artifact rather than a real change ASPH EPIDEMIOLOGY COMPETENCIES ADDRESSED C. 3. Describe a public health problem in terms of magnitude, person, place, and time C. 6. Apply the basic terminology and definitions of epidemiology C. 7. Calculate basic epidemiology measures C. 9. Draw appropriate inference from epidemiologic data C. 10. Evaluate the strengths and limitations of epidemiologic reports ASPH INTERDISCIPLINARY/CROSS-CUTTING COMPETENCIES ADDRESSED F.1. [Communication and Informatics] Describe how the public health information infrastructure is used to collect, process, maintain, and disseminate data J.1. [Professionalism] Discuss sentinel events in the history and development of the public health profession and their relevance for practice in the field L.2. [Systems Thinking] Identify unintended consequences produced by changes made to a public health system This material was developed by the staff at the Global Tuberculosis Institute (GTBI), one of four Regional Training and Medical Consultation Centers funded by the Centers for Disease Control and Prevention. It is published for learning purposes only.